Article Information
History
- October 30, 2022.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Nafisa J. Wara1,§,
- Rufaro Mvududu2,
- Mary M. Marwa3,
- Laurén Gómez4,
- Nyiko Mashele2,
- Catherine Orrell5,
- Corrina Moucheraud6,
- John Kinuthia3,4,
- Grace John-Stewart4,7,8,9,
- Landon Myer2,
- Risa Hoffman10,
- Jillian Pintye4,11 and
- Dvora L. Joseph Davey2,10,12
- 1David Geffen School of Medicine at the University of California, Los Angeles, Los Angeles, California, USA
- 2Division of Epidemiology and Biostatistics, School of Public Health, University of Cape Town, Cape Town, South Africa
- 3Department of Research and Programs, Kenyatta National Hospital, Nairobi, Kenya
- 4Department of Global Health, University of Washington, Seattle, Washington, USA
- 5Desmond Tutu HIV Centre, Institute of Infectious Disease and Molecular Medicine and the Department of Medicine, University of Cape Town, South Africa
- 6Department of Health Policy and Management, Fielding School of Public Health, University of California Los Angeles, Los Angeles, California, USA
- 7Department of Epidemiology, University of Washington, Seattle, Washington, USA
- 8Department of Medicine, University of Washington, Seattle, Washington, USA
- 9Department of Pediatrics, University of Washington, Seattle, Washington, USA
- 10Division of Infectious Diseases, David Geffen School of Medicine at the University of California, Los Angeles, Los Angeles, California, USA
- 11Department of Biobehavioral Nursing and Health Informatics, University of Washington, Seattle, Washington, USA
- 12Department of Epidemiology, Fielding School of Public Health, University of California Los Angeles, Los Angeles, California, USA
- ↵§Correspondence:
Nafisa Wara, Email: nwara{at}mednet.ucla.edu, Telephone: 518-577-3170, Address: 10833 Le Conte Ave, Los Angeles CA 90095
Posted October 30, 2022.
Preferences and Acceptability for Long-Acting PrEP Agents Among Pregnant and Postpartum Women with Experience Using Daily Oral PrEP in South Africa and Kenya
